We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Optiscan signs collaborative research agreement with the University of Minnesota College of Veterin...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleAussie shares slip as RBA holds rates steady MinRes rebounds, Domino’s Don Meij quits Investors ret...
Read ArticleOptiscan enters deal with Monash University to progress project of developing a scope-agnostic GI...
Read ArticleTelix Pharmaceuticals will benefit from ongoing favourable US pay arrangements for high-value radio...
Read ArticleWorld Health Organsiation projects a shortfall of 10 million health workers by 2030 HeraMED’s platf...
Read ArticleStockhead’s Sarah Hughan sits down with Optiscan’s (ASX:OIL) CEO and managing director Dr Camile Far...
Read ArticleOptiscan’s confocal laser endomicroscopy enables real-time imaging of tissue and avoids the need fo...
Read ArticleNew technologies are transforming healthcare and challenging traditional medical practices Optiscan...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleAustralia’s clinical trials sector generated $1.6bn for the nation’s economy in 2022 according to M...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleASX flattish on Monday, with utilities and gold stocks leading A2 Milk’s shares plummeted 20pc amid...
Read ArticleOptiscan inks deal with the University of Minnesota College of Veterinary Medicine Deal will deve...
Read ArticleControl Bionics to gain US$4,300 reimbursement for its NeuroNode device Noxopharm begins a trial fo...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleSeveral ASX healthcare companies are proudly manufacturing products in Australia Polynovo, Optisca...
Read ArticleStockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episod...
Read ArticleCommercial-stage medical technology company Optiscan Imaging (ASX: OIL) has completed beta phase tes...
Read ArticleOptiscan to showcase its innovative cloud-based telepathology platform dorsaVi seals crucial contra...
Read ArticleVital Signs is a podcast series focused on investing, hosted by Senior Health and Biotech journalist...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companie...
Read ArticleThe ASX200 closed the day in the red, down 0.3%. It was a rough day for the Energy sector, fallin...
Read ArticleAussie shares down on weaker commodities Iron ore and energy stocks slip, while goldies gain Intel...
Read ArticleOptiscan (ASX: OIL) has unveiled InVue, a new microscopic medical imaging device, designed to enabl...
Read ArticleOptiscan unveils the InVue next-gen microscopic medical imaging device for precision surgery InVue...
Read ArticleOptiscan Imaging (ASX: OIL) has revealed the InVue microscopic medical imaging device, designed to b...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleOptiscan enters know-how agreement with world-renowned Mayo Clinic for major pathology breakthrough...
Read ArticleThe ASX200 closed fractionally up by 0.01 of a per cent. Energy had a rough run – slipping around...
Read ArticleASX flat on Monday, ahead of Federal Budget Tuesday night Oil weakness drags Energy sector lower C...
Read ArticleOptiscan Imaging (ASX:OIL) is set to partner with Mayo Clinic to develop a cutting-edge digital conf...
Read ArticleOptiscan signs deal with world-renowned Mayo Clinic AdAlta designates Cell Therapies as its manufac...
Read ArticleASX closed higher on Friday as energy stocks lifted Oil prices up as Middle East conflict intensifi...
Read ArticleOptiscan Imaging says its latest financial results are just the tip of the iceberg, confident a stro...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleSeveral ASX medtech companies have upcoming catalysts in 2024 as they look to transform healthcare ...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleMomentum investing involves taking advantage of, and making profits from, upward trends in a stock....
Read ArticleMedical device manufacturer Optiscan Imaging has expanded its U.S push, opening an office in the bio...
Read ArticleThe ASX200 ends Tuesday slightly lower Resources stocks hold the fort, everyone else AWOL Small Ca...
Read ArticleSpecial Report: Optiscan is beefing up its presence in the US as it works toward securing US regulat...
Read ArticleOptiscan Imaging (ASX:OIL) has announced the establishment of its US Regional Office in Roch...
Read ArticleOptiscan Imaging’s ongoing studies aimed at producing revolutionary medical imaging devices have rec...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleEarly detection and effective treatment can lead to remission or cure for many cancers Optiscan’s t...
Read ArticleStockhead’s Ashtyn Hiron sits down with Optiscan (ASX:OIL) CEO And Managing Director Dr. Camile Fara...
Read ArticleUS inflation data came in higher than tipped, rattling the markets over there, with the ripple effec...
Read ArticleOptiscan Imaging is investigating how it can use AI in the cancer-fighting technology it believes co...
Read ArticleA money trail is forming behind Optiscan Imaging’s technology-based mission to tackle the scourge of...
Read ArticleOptiscan’s platform could help with shortage of pathologists in Australia and globally Platform par...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleOptiscan Imaging has strengthened its mission aimed at breaking into the US health market or with it...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleOptiscan Imaging is on a mission to prove its technology can provide surgeons with the exact extent...
Read ArticleOptiscan Imaging (ASX:OIL) has provided an interim readout on its Breast Cancer Intraoperati...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleOptiscan Imaging has ticked off a major milestone in developing its telepathology platform, with the...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleOptiscan Imaging says it has successfully raised $16.7 million from a recent entitlement issue as th...
Read ArticleOptiscan Imaging has been invited to present its remarkable confocal endomicroscopic medical imaging...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleOptiscan Imaging (ASX:OIL) has launched an entitlement offer to raise $16.7 million it says...
Read ArticleOptiscan Imaging has revealed a $16.7 million mission to fast-track the development of its revolutio...
Read ArticleOptiscan Imaging (ASX:OIL) has announced the publication of readout results of its oral canc...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleAustralian company Optiscan Imaging (ASX:OIL) has announced the establishment of a new comme...
Read ArticleThe medical imaging market size globally is forecast to reach $68.8 Billion by 2030 Several ASX hea...
Read ArticleSeveral ASX health stocks are seeking US FDA approval for drugs/devices in the near future Telix P...
Read ArticleOptiscan Imaging (ASX:OIL) has announced the interim results of its oral imaging study condu...
Read ArticlePatrys says pre-clinical data supports its drug’s synthetic lethality mechanism Alterity granted pa...
Read ArticleA recent Optiscan Imaging (OIL) study shows the company’s technology is “extremely accurate” for the...
Read ArticleUS bank stocks were rattled on concerns of a contagion from SVB collapse Bond yields tumbled, lifti...
Read ArticleOptiscan Imaging has announced an exclusive collaboration with Canadian-based Prolucid Techn...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleOptiscan Imaging (OIL) partners with software developer Prolucid Technologies to develop AI algorith...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleASX 200 holds steady around +0.8% since lunch Australian Pacific Coal CEO David Conry has left the...
Read ArticleASX 200 edges higher, small cap index falls 0.44% 7 out of 11 sectors were in the green with Tech...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleHighlights The S&P/ASX200 closed on a higher note today (25 October), gaining 0.28% to end a...
Read ArticleOptiscan Imaging (OIL) enters a binding term sheet with Managing Director Professor Camile Farah to...
Read ArticleASX closes out the day lower by about 0.74% Online matchmakers Love Group goes on a bodice-busting...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleOptiscan Imaging (ASX:OIL) has announced the submission to the US FDA of a pre-market notifi...
Read ArticleSmall cap index up 1.1%, stronger than benchmark, but both do good, run hard. Wall Street snaps 3...
Read ArticleOptiscan Imaging (OIL) submits a Food and Drug Administration (FDA) Pre-Market Notification (510(k)...
Read ArticleImaging specialist Clarity opens patient recruitment in Australia and will start Phase 2 trial soon...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleThe ASX has trundled along like a happy little camper, up nearly 1.0% SZL sizzled then fizzled as t...
Read ArticleSmall cap index up 3% ASX 200 is up 1% Wall Street jumps as The Fed asks how high The ASX 200 is u...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleOptiscan Imaging (OIL) releases further information on its new partnership deal at the request of t...
Read ArticleOptiscan Imaging (OIL) joins forces with a strategic distribution partner in China The company penn...
Read ArticleASX is set to open sharply higher today after Friday’s big rally on Wall Street US major banks pass...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleWith Tuesday trade in the casket, the ASX Emerging Companies (XEC) index has closed about 1% lower,...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleThe ASX Emerging Companies (XEC) index is busting out after a three-session losing streak that felt...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleOptiscan Imaging’s (OIL) Non-Executive Director will step into the role of Managing Director after...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleOptiscan Imaging (OIL) completes the patient recruitment and imaging component of its breast cancer...
Read ArticleThe ASX 200 Health Index (XHJ) is down by 2.2% at the time of writing, compared to the broader index...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleIn FY21 the ASX 200 returned over 20 per cent but the 100 best performing ASX stocks all gained over...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleSummary The ASX 200 closed lower by 19 points or 0.27% at 7142.60. The Australian dollar and bo...
Read ArticleThe USA is the world’s largest healthcare market and therefore a dream for ASX health stocks to ente...
Read ArticleThe diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two tec...
Read ArticleFor all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t chang...
Read ArticleSummary Oncology player Telix Pharmaceuticals has commenced Phase 3 clinical trial of its prosta...
Read ArticleGoogle April 2021 and the first things you’ll find isn’t ASX winners but questions about COVID-19. J...
Read ArticleSummary Growth stocks are associated with generating a high return, although the risk associated...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleThe “hottest ASX stock” – in other words, the stock with the highest RSI – this week is Rumble Resou...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleThe OptiScan Imaging Limited (ASX: OIL) share price is one of the best performers on the ASX today....
Read ArticleSource: Vitalii Vodolazskyi, Shutterstock Summary Golden Rim Resources is trading massively up...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleIn February, ASX fintech stocks were winners, losers and winners again. The benchmark ASX 200 index...
Read ArticleThe Optiscan Imaging Limited (ASX: OIL) share price took flight today as the company announced the...
Read ArticleThe Optiscan Imaging Limited (ASX: OIL) share price is climbing higher today after a positive annou...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The health sector made a bit...
Read ArticleA quick wrap of the ASX’s key winners and losers on Monday, September 7. Data is taken after the mar...
Read ArticleOur summary of Optiscan Imaging Ltd's recent announcement What's happened? Optiscan Imaging Limited...
Read ArticleA quick wrap of the key winners and losers on Friday, June 26. Data is taken after the market closes...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleCancer-fighting biotech Immutep (ASX:IMM) has risen off 10-year-long lows after flagging a payment o...
Read ArticleMedical equipment maker Optiscan Imaging (ASX: OIL) has achieved a significant milestone as part of...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
